There is no website visitor data available for this stock.
---
AGE FAQ
What was AgeX Therapeutics Inc’s price range in the past 12 months?
AgeX Therapeutics Inc lowest stock price was $10.90 and its highest was $35.17 in the past 12 months.
What is AgeX Therapeutics Inc’s market cap?
Currently, no data Available
When is AgeX Therapeutics Inc’s upcoming earnings report date?
AgeX Therapeutics Inc’s upcoming earnings report date is May 15, 2024 which is in 48 days.
How were AgeX Therapeutics Inc’s earnings last quarter?
AgeX Therapeutics Inc released its earnings results on Mar 22, 2024. The company reported -$3.203 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.203.
AgeX Therapeutics Inc does not currently pay dividends.
What is AgeX Therapeutics Inc’s EPS estimate?
AgeX Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AgeX Therapeutics Inc have?
AgeX Therapeutics Inc has 2,500,747 shares outstanding.
What happened to AgeX Therapeutics Inc’s price movement after its last earnings report?
AgeX Therapeutics Inc reported an EPS of -$3.203 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.3%.
Which hedge fund is a major shareholder of AgeX Therapeutics Inc?
Among the largest hedge funds holding AgeX Therapeutics Inc’s share is Defender Capital, LLC.. It holds AgeX Therapeutics Inc’s shares valued at N/A.
AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.